Skip to main content
Log in

The dosimetry of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane

  • Short Communication
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

This report documents the radiation dosimetry of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane [123I]β-CIT in humans. The mean absorbed doses for various organs and the effective dose equivalent were estimated from whole-body scans, blood samples and single-photon emission tomography scans acquired up to 22 h after the injection of a known amount of tracer. The basal ganglia, the liver and the lower large intestinal wall received the highest mean absorbed doses of 0.270 mGy/MBq, 0.038 mGy/MBq and 0.034 mGy/MBq, respectively. The effective dose equivalent for adults was estimated using 11 organs and the ICRP-87 radiation dose model and was 0.031 mSv/MBq. The radiation dose to the basal ganglia limits the maximum injected activity of [123I]β-CIT to 185 MBq for a single study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Innis R, Baldwin R, Sybirska E, et al. Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT. Eur J Pharmacol 1991;200: 369–370.

    Google Scholar 

  2. Neumeyer JL, Wang S, Milius RA, et al. [123I]2β-Carbomethoxy-3β-(4-iodophenyl)tropane (β-CIT): high affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 1991;34: 3144–3146.

    Google Scholar 

  3. Kuikka JT, Bergstrom KA, Vanninen E, Laulumaa V, Hartikainen P, Lansimies E. Initial experience with SPET examinations using [123I]-2β-carbomethoxy-3-β-(4-iodophenyl)tropane ([123I]β-CIT) in human brain. Eur J Nucl Med 1993;20: 783–786.

    Google Scholar 

  4. Innis RB, Seibyl JB, Wallace E et al. SPECT imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease [abstract]. J Nucl Med 1993;31: 31P.

  5. Kuikka JT, Tenhunen-Eskelinen M, Jurvelin J, Kiiliäinen H. Physical performance of the Siemens MultiSPECT 3 gamma camera. Nucl Med Commun 1993;14: 490–497.

    Google Scholar 

  6. Ellet WH, Humes RM. Absorbed fractions for small volumes containing photon-emitting radioactivity. MIRD Suppl 5, Pamphlets 7–8. New York: The Society of Nuclear Medicine, 1971.

    Google Scholar 

  7. Weber DA, Eckerman KE, Dillman LT, Ryman JC. MIRD: radionuclide data and decay schemas. New York: The Society of Nuclear Medicine, 1989.

    Google Scholar 

  8. ICRP. Radiation dose to patients from radiopharmaceuticals. ICRP publication 53. Oxford: Pergamon Press, 1987.

    Google Scholar 

  9. 123I-IBZM package insert. Cygne b.v. Eindhoven, The Netherlands, 1993.

  10. Verhoeff NPGL, Busemann-Sokole E, Hengst D, Stubbs JB, van Royen EA. Dosimetry of iodine-123 iomazenil in humans. Eur J Nucl Med 1993;20: 580–584.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuikka, J.T., Bergström, K.A., Ahonen, A. et al. The dosimetry of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane. Eur J Nucl Med 21, 53–56 (1994). https://doi.org/10.1007/BF00182306

Download citation

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00182306

Key words

Navigation